• Polycystic Kidney Disease, Autosomal Dominant (PKD1 and PKD2), Gene Analysis
  • Antinuclear Antibody (ANA) Screen
  • Cytochrome P450 2E1 (CYP2E1) Genotyping
  • Protein, Total, Random, Urine
  • Cerebrospinal Fluid Microscopic Evaluation, Cell Count and Differentiation
  • Platelet Count
  • TNNI3 (Troponin I) Gene Mutation Analysis
  • Influenza Virus Type A and B, Culture
  • Peutz-Jeghers Syndrome (STK11) Gene Mutation Analysis
  • Erythropoietin Receptor (EPOR) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Antinuclear Antibody (ANA) Screen
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Antinuclear Antibody (ANA) Screen
Medical Test

Methodology
Access to Antinuclear Antibody (ANA) Screen is restricted.
Loading...